On November 12, 2024, Simon Campion, President, CEO & Member of the Board of Directors of Dentsply Sirona Inc (XRAY, Financial), purchased 11,306 shares of the company, as reported in a recent SEC Filing. Following this transaction, the insider now owns a total of 272,247.3911 shares of Dentsply Sirona Inc.
Dentsply Sirona Inc is a global manufacturer of professional dental products and technologies, with a wide range of dental supplies including dental anesthetics, dental sealants, diagnostic products, and dental implants.
Over the past year, Simon Campion has engaged in multiple transactions, purchasing a total of 21,306 shares and selling none. This pattern of insider buying could be significant, as it reflects the actions of executives who are potentially optimistic about the firm's future prospects.
The broader insider transaction trend for Dentsply Sirona Inc shows a total of 6 insider buys over the past year, with no insider sales during the same period, indicating a possible positive sentiment within the company's upper management about the stock's future.
On the date of the latest purchase by Simon Campion, shares of Dentsply Sirona Inc were trading at $17.72. This pricing values the company with a market cap of approximately $3.45 billion.
According to the GF Value, the intrinsic value of the stock is estimated at $35.79, which suggests that the stock is currently undervalued, with a price-to-GF-Value ratio of 0.5. This valuation indicates that the stock might be a Possible Value Trap, and investors should think twice before making an investment decision.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted for the company's past performance and expected future business results.
This recent insider purchase by Simon Campion could be a key indicator for potential investors, reflecting a commitment by top management to the company's ongoing success and growth.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
